Schizophrenia Drugs Market Forecasted at $9.46 Billion by 2030, Driven by the Rising Focus on Injectable Treatments and Second-Generation Therapeutics
January 31, 2024 09:42 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Schizophrenia Drugs Market, Size, Global Forecast Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis"...
Bipolar Disorder Therapeutics Global Market Report 2022: Featuring Key Players AbbVie, Pfizer, GlaxoSmithKline & Others
September 13, 2022 07:18 ET
|
Research and Markets
Dublin, Sept. 13, 2022 (GLOBE NEWSWIRE) -- The "Bipolar Disorder Therapeutics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global bipolar disorder...
Worldwide Bipolar Disorder Drugs and Treatment Industry to 2032 - by Drug Class and Region
June 03, 2022 06:18 ET
|
Research and Markets
Dublin, June 03, 2022 (GLOBE NEWSWIRE) -- The "Global Bipolar Disorder Drugs and Treatment Market 2022-2032" report has been added to ResearchAndMarkets.com's offering. A recent market study...
United States Depression Drugs Market 2021-2026 - Branded & Generic Availability, Dosage Patent & Price Analysis
March 05, 2021 05:53 ET
|
Research and Markets
Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026" report has been added to ResearchAndMarkets.com's offering. The complete...
Global Antipsychotic Drugs Industry (2020 to 2027) - Market Trends and Drivers
December 09, 2020 07:08 ET
|
Research and Markets
Dublin, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The "Antipsychotic Drugs - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years...